| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
02.02.2011 US 201161438780 P
|
| (43) |
Date of publication of application: |
|
26.12.2012 Bulletin 2012/52 |
| (73) |
Proprietor: University of Southern California |
|
Los Angeles, CA 90089-2561 (US) |
|
| (72) |
Inventors: |
|
- RODGERS, Kathleen, E.
Long Beach, CA 90815 (US)
- DIZEREGA, Gere, S.
San Luis Obispo, CA 93401 (US)
|
| (74) |
Representative: Ettmayr, Andreas et al |
|
KEHL, ASCHERL, LIEBHOFF & ETTMAYR
Patentanwälte
Emil-Riedel-Strasse 18
80538 München
80538 München (DE) |
| (56) |
References cited: :
|
| |
|
|
- RODGERS K E ET AL: "Fragments of Nle3-angiotensin(1-7) accelerate healing in dermal
models", JOURNAL OF PEPTIDE RESEARCH, BLACKWELL PUBLISHING LTD, OXFORD; GB, vol. 66,
no. SUPPL. 1, 1 December 2005 (2005-12-01), pages 41-47, XP002643256, ISSN: 1397-002X
- RODGERS K E ET AL: "ACCELERATION OF HEALING, REDUCTION OF FIBROTIC SCAR, AND NORMALIZATION
OF TISSUE ARCHITECTURE BY AN ANGIOTENSIN ANALOGUE, NORLEU3-A(1-7)", PLASTIC AND RECONSTRUCTIVE
SURGERY, WILLIAMS AND WILKINS CO., BALTIMORE, MD, US, vol. 111, no. 3, 1 March 2003
(2003-03-01) , pages 1195-1206, XP008059840, ISSN: 0032-1052, DOI: 10.1097/01.PRS.0000047403.23105.66
- KATHLEEN E. RODGERS ET AL: "Histological evaluation of the effects of angiotensin
peptides on wound repair in diabetic mice", EXPERIMENTAL DERMATOLOGY, vol. 12, no.
6, 1 December 2003 (2003-12-01), pages 784-790, XP55032955, ISSN: 0906-6705, DOI:
10.1111/j.0906-6705.2003.00087.x
- US-NIH: "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers",
, 14 May 2010 (2010-05-14), XP002680220, Retrieved from the Internet: URL:http://web.archive.org/web/20100514120
507/http://www.clinicaltrials.gov/ct2/show /NCT00796744? [retrieved on 2012-07-17]
- MATUSZEWSKA BOZENA ET AL: "Acidic fibroblast growth factor: Evaluation of topical
formulations in a diabetic mouse wound healing model", PHARMACEUTICAL RESEARCH (NEW
YORK), vol. 11, no. 1, 1994, pages 65-71, XP009161289, ISSN: 0724-8741
- PETER P. BALINGIT ET AL: "NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing:
Results of a randomized, parallel-group, double-blind, placebo-controlled phase 2
clinical trial", WOUND REPAIR AND REGENERATION, 1 July 2012 (2012-07-01), pages N/A-N/A,
XP55032963, ISSN: 1067-1927, DOI: 10.1111/j.1524-475X.2012.00804.x
- CARNEY D H ET AL: "Could rusalatide acetate be the future drug of choice for diabetic
foot ulcers and fracture repair?", EXPERT OPINION ON PHARMACOTHERAPY 200810 GB LNKD-
DOI:10.1517/14656566.9.15.2717, vol. 9, no. 15, October 2008 (2008-10), pages 2717-2726,
XP009161260, ISSN: 1465-6566
|
|
